News | Radiation Therapy | February 04, 2016

RAD Technology Patents Modular Cancer Treatment Facilities

Modular construction approach offers increased financial and technological flexibility in one-third the time of traditional construction methods

RAD Technology, modular cancer treatment facilities, radiation vaults, U.S. patent

February 4, 2016 — RAD Technology Medical Systems (RAD) has added a new patent to its expanding portfolio of modular building technologies for cancer treatment facilities. Issued by the United States Patent Office on Oct. 27, 2015, the patent protects specialized means and methods to construct high-energy radiation vaults. RAD also received a patent earlier in May 2015 on its Temporary Radiotherapy Vault (TRV).

The RAD approach is driven by three key values:

  • Time: The solutions offered by RAD can be delivered in one-third the time of traditional construction methods. This impacts patient accessibility to the latest care and gives institutions an edge over competitors looking to enter their market. RAD can install its TRV cancer facility and perform a radiation survey with its pre-commissioned linear accelerator (linac) in just five days.
  • Technology: The modular technology also provides significant value and flexibility. In traditional construction, both the shielding and machine requirements are cast into the concrete structure. RAD offers a component approach to equipment installation, facilitating future upgrades along with a shielding method that can be modified without the cost and disruption of expensive lead and high density block solutions.
  • Unique Financing: One of the most distinctive values is the financing approach the RAD solutions offer. A recoverable asset, without destructive demolition, can be treated as equipment or tangible personal property, allowing operational leases to be structured for large institutions not seeking to deploy capital or wishing to avoid further impairment of their balance sheets with debt.

New revenue opportunities can be stalled during the arduous and lengthy struggle to free up capital. With an off balance sheet lease made possible by RAD's patented modular technology, institutions can develop facilities and services, open new markets and start generating revenue within a few months without debt impairment, bypassing the months or years it otherwise takes for capital funding to be available.

According to The Lancet Oncology Commission's report presented at the 2015 European Cancer Congress in Vienna, Austria, low and middle income countries have 80 percent of the global cancer burden but only 5 percent of the resources for cancer control. This illustrates the potential international demand that may benefit from the patented RAD modular system.

For more information:

Related Content

Penn Medicine Treats World's First Patient on Varian's Halcyon System
News | Radiation Therapy | September 22, 2017
September 22, 2017 — Varian Medical Systems announced a patient at Penn Medicine, with head & neck cancer, became
BrainLAB Announces FDA Clearance For Two New Indication-Specific Radiosurgery Software Applications
Technology | Treatment Planning | September 21, 2017
Brainlab announced that it has received U.S. Food and Drug Administration (FDA) clearance for Elements Spine SRS and...
Accuray Showcases CyberKnife and Radixact Systems at ASTRO 2017
News | Radiation Therapy | September 21, 2017
Accuray Inc. announced that data and first-hand experience with its advanced CyberKnife and Radixact Systems will be...
RayCare Oncology Information System Being Shown at ASTRO 2017
News | Radiation Therapy | September 20, 2017
RaySearch will be exhibiting its next-generation oncology information system (OIS) RayCare, among other highlights, at...
ProCure Proton Therapy Center New Jersey Celebrates Five-Year Cancer-Free Milestone for Prostate Cancer Patients
News | Proton Therapy | September 20, 2017
ProCure Proton Therapy Center in Somerset, N.J., recently celebrated the five-year cancer-free milestone for the first...
Varian to Showcase Latest Radiation Therapy Technologies and Software at ASTRO 2017
News | Radiation Therapy | September 19, 2017
Varian Medical Systems announced it will be demonstrating its new Halcyon platform and HyperArc high-definition...
Elekta to Highlight MOSAIQ Oncology Analytics at ASTRO Annual Meeting
News | Radiation Therapy | September 19, 2017
September 19, 2017 — Elekta will highlight its Mosaiq Oncology...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Clinical Trials and Cutting-Edge Radiation Oncology Research to Be Featured at ASTRO 2017
News | Radiation Therapy | September 14, 2017
The program for the 2017 Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 24-27 in San...
Provision Healthcare Joins RayCare Clinical Partners
News | Oncology Information Management Systems (OIMS) | September 11, 2017
Provision, located in Knoxville, Tenn., is the latest to partner with RaySearch Laboratories on the development of its...
Overlay Init